α细胞使用PC1/3和PC2来处理前葡萄糖和控制胰岛素分泌
Canqi Cui1, Danielle C Leander1, Sarah M Gray1
1Duke Molecular Physiology Institute, Durham, NC, USA.
Science advances
|September 19, 2025
概括
阿尔法细胞通过膜信号与β细胞进行通信. 这项研究表明,葡萄糖在小鼠中介于这种作用,但α细胞可以产生GLP-1来增强葡萄糖耐受性和胰岛素分泌.
科学领域:
- 内分泌学 在内分泌学.
- 代谢过程中的代谢.
- 细胞生物学 细胞生物学
背景情况:
- 阿尔法细胞通过proglucagon调节营养代谢.
- 一个α细胞到β细胞轴涉及通过葡萄糖和GLP-1受体传递帕克林信号.
研究的目的:
- 为了确定哪些葡萄糖可以刺激胰岛素分泌.
- 为了研究前激素转化酶在加工前葡萄糖中的作用.
- 为了比较GLP-1水平和老鼠和人类的α-β细胞通信.
主要方法:
- 开发了一种测量方法来定量GLP-1 ((7-36) NH2水平.
- 产生了转基因小鼠线路,用于诱导前葡萄糖加工酶的缺失.
- 分析了小岛组成和小鼠和人类的水平.
主要成果:
- 鼠标和人类的小岛都含有GLP-1 ((7-36) NH2.2.
- 葡萄糖在小鼠中介于α-β细胞通信.
- 当葡萄糖的产生受到损害时,α细胞上调PC1/3以产生GLP-1,从而增强葡萄糖耐受性.
- 人类小岛的GLP-1水平较高,与胰岛素分泌率相关.
结论:
- 葡萄糖的处理表现出可塑性,以支持α-β细胞通信.
- GLP-1在人类小岛的功能和胰岛素分泌中起着重要作用.
- 了解这些途径为代谢调节提供了洞察力.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.2K
Hormones Regulating Blood Glucose
6.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.5K
Cells and Secretions of the Pancreas
4.4K
The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
4.4K
Insulin Secretory Vesicles
6.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.4K
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Glucagon-like Receptor Agonists
850
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
850


